insights_auto
Outlook: 22.2% bullish·16.7% bearish
Go to analysischevron_right
A1RG34:BVMF
Argenx Se Bdr
၁၆၅.၄၄ R$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၉, GMT-၃ ၁၆:၅၆:၀၀ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
၁၆၅.၄၄ R$
High
၁၆၅.၄၄ R$
Low
၁၆၅.၄၄ R$
Mkt. cap
ဋေ ၅.၀၁ ထ
Avg. vol.
၅၉.၀၀
Volume
၈.၀၀
52-wk high
၂၁၃.၁၅ R$
52-wk low
၁၄၃.၂၂ R$
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
Open
၁၆၅.၄၄ R$
High
၁၆၅.၄၄ R$
Low
၁၆၅.၄၄ R$
Mkt. cap
ဋေ ၅.၀၁ ထ
Avg. vol.
၅၉.၀၀
Volume
၈.၀၀
52-wk high
၂၁၃.၁၅ R$
52-wk low
၁၄၃.၂၂ R$
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁ ရက်
Argenx stock sits at EUR 736.30 after a week of mixed trial news
AD HOC NEWS
·
ပြီးခဲ့သည့် ၂ ရက်
Argenx stock pre-market: EUR 729.20, prior close EUR 729.90
WSJ
·
ပြီးခဲ့သည့် ၃ ရက်
Argenx Shares Plunge After Autoimmune-Disease Trial Halt
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr